Moneycontrol > News > Announcements

Aug 03, 2012, 01.09 PM IST

Ranbaxy Enter into in-Licensing agreement with Gilead Sciences

Ranbaxy Enter into in-Licensing agreement with Gilead Sciences

Source: Moneycontrol.com
Share Share on Tumblr
Share  .  Email  .  Print  .  A+
Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated August 03, 2012 titled " Ranbaxy Enter into an In-Licensing Agreement with Gilead Sciences to Promote Access to Reduced Cost Generic Emtricitabine And Emtricitabine-Containing Fixed-Dose Antiretrovirals in Developing Countries".Source : BSE

Read all announcements in Ranbaxy Labs


Set email alert for

Nokia may develop 'larger-sized handsets': Report
Tale of two Sakshis, Sreesanth and their Jaipur connection "Tale of two Sakshis, Sreesanth and their Jaipur connection "

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

May 22 2013, 13:11

Nifty to consolidate; go long above 6200: ICICI Direct

- in MARKET OUTLOOK